BioSig Technologies signs new licencing agreements with Mayo Clinic
Under the new licencing agreements, the companies will focus on previously untapped arrhythmia treatments
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
27 Nov 19
Under the new licencing agreements, the companies will focus on previously untapped arrhythmia treatments
21 Nov 19
Reduction of patient complications and hospital resource utilization after heart surgery demonstrated with use of the PleuraFlow ACT…
21 Nov 19
LivaNova’s Saluggia facility in Italy is dedicated for R&D and production of mechanical heart valves, rings, accessories, and…
21 Nov 19
ZILVERPASS trial is a randomised, multicentre clinical study that enrolled 220 patients across four countries to evaluate Zilver…
19 Nov 19
Leading interventional cardiologist has used CorPath vascular robotic technology to successfully demonstrate feasibility of long-distance, multi-location remote procedures…
14 Nov 19
PEDRA Technology designed by Proximo Medical provides real-time perfusion monitoring
12 Nov 19
The Micra TPS has been approved by the US Food and Drug Administration (FDA) in April 2016, for…
08 Nov 19
The MiniBox+, a desktop, cabinless device, is used by specialists and primary care physicians for complete Pulmonary Function…
07 Nov 19
Penumbra Indigo Aspiration System is a continuous mechanical thrombectomy system that removes blood clots from the arteries and…
07 Nov 19
CLTI is the most severe form of PAD and often occurs in patients suffering from coronary artery disease,…